Anna Emde

742 total citations
15 papers, 557 citations indexed

About

Anna Emde is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Anna Emde has authored 15 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Anna Emde's work include HER2/EGFR in Cancer Research (6 papers), Advanced Breast Cancer Therapies (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Anna Emde is often cited by papers focused on HER2/EGFR in Cancer Research (6 papers), Advanced Breast Cancer Therapies (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Anna Emde collaborates with scholars based in Israel, United States and Germany. Anna Emde's co-authors include Eran Hornstein, Yosef Yarden, Wolfgang J. Köstler, Kurt Possinger, Jan Eucker, Maricarmen D. Planas-Silva, Hongyu Liu, Elena Elstner, Carsten‐Oliver Schulz and Chuanbing Zang and has published in prestigious journals such as Journal of Clinical Oncology, The EMBO Journal and Oncogene.

In The Last Decade

Anna Emde

12 papers receiving 553 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Emde Israel	9	330	141	141	90	86	15	557
Severa Bunda Canada	18	608 1.8×	150 1.1×	177 1.3×	24 0.3×	140 1.6×	27	1.0k
Shengping Yu China	16	444 1.3×	202 1.4×	256 1.8×	60 0.7×	200 2.3×	45	883
KangAe Lee United States	6	444 1.3×	175 1.2×	391 2.8×	24 0.3×	42 0.5×	6	832
Wanfu Xie China	17	315 1.0×	145 1.0×	183 1.3×	36 0.4×	138 1.6×	28	569
Paturu Kondaiah India	13	288 0.9×	129 0.9×	197 1.4×	26 0.3×	186 2.2×	19	584
In Hwa Bae South Korea	17	595 1.8×	141 1.0×	329 2.3×	9 0.1×	36 0.4×	29	823
Imade Aït-Arsa France	11	205 0.6×	153 1.1×	73 0.5×	22 0.2×	10 0.1×	14	440
Ufuk Degirmenci Singapore	7	480 1.5×	128 0.9×	222 1.6×	11 0.1×	25 0.3×	7	653
Vincent Beuger United States	8	642 1.9×	339 2.4×	84 0.6×	23 0.3×	26 0.3×	8	810
Valérie Pawlowski France	12	404 1.2×	213 1.5×	98 0.7×	42 0.5×	14 0.2×	17	752

Countries citing papers authored by Anna Emde

Since Specialization

Citations

This map shows the geographic impact of Anna Emde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Emde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Emde more than expected).

Fields of papers citing papers by Anna Emde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Emde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Emde. The network helps show where Anna Emde may publish in the future.

Co-authorship network of co-authors of Anna Emde

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Emde. A scholar is included among the top collaborators of Anna Emde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Emde. Anna Emde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Mehtälä, Juha, et al.. (2025). Size and Treatment Outcomes of HR+, HER2- Early Breast Cancer Population With High Risk of Recurrence: A Real-World Cohort Study With Danish Breast Cancer Cooperative Group Registry Data. Journal of health economics and outcomes research. 12(1). 252–260.

Blancas, Isabel, Jessica Grosjean, R. Pedersini, et al.. (2024). Abemaciclib for treating patients with HR+/HER2- metastatic breast cancer: a real-world study in France, Italy and Spain. Future Oncology. 20(31). 2371–2384.

Huober, J., et al.. (2024). Oral Anticancer Therapies: Addressing Nonadherence in Patients With Breast Cancer. Clinical Breast Cancer. 25(4). 307–324.

Johnston, Stephen, Anna Emde, Carlos H. Barrios, et al.. (2023). Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors: existing and emerging differences. JNCI Cancer Spectrum. 7(4). 7 indexed citations

Silvestroni, Aurelio, Yishai Levin, Robert Sons, et al.. (2020). Dysregulated miRNA biogenesis downstream of cellular stress and ALS-causing mutations: a new mechanism for ALS. UNC Libraries. 5 indexed citations

Emde, Anna, Chen Eitan, Iddo Magen, et al.. (2015). Dysregulated mi RNA biogenesis downstream of cellular stress and ALS ‐causing mutations: a new mechanism for ALS. The EMBO Journal. 34(21). 2633–2651. 154 indexed citations

Tod, Michel, Anna Emde, Yosef Yarden, et al.. (2015). Modeling and predicting optimal treatment scheduling between the antiangiogenic drug sunitinib and irinotecan in preclinical settings. CPT Pharmacometrics & Systems Pharmacology. 4(12). 720–727. 11 indexed citations

Emde, Anna & Eran Hornstein. (2014). mi RNA s at the interface of cellular stress and disease. The EMBO Journal. 33(13). 1428–1437. 89 indexed citations

Zeisel, Amit, Wolfgang J. Köstler, Mattia Lauriola, et al.. (2011). Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions. Oncogene. 31(31). 3569–3583. 31 indexed citations

10.

Emde, Anna, et al.. (2011). Simultaneous Inhibition of Estrogen Receptor and the HER2 Pathway in Breast Cancer: Effects of HER2 Abundance. Translational Oncology. 4(5). 293–300. 20 indexed citations

11.

Emde, Anna, Wolfgang J. Köstler, & Yosef Yarden. (2010). Therapeutic strategies and mechanisms of tumorigenesis of HER2-overexpressing breast cancer. Critical Reviews in Oncology/Hematology. 84. e49–e57. 42 indexed citations

12.

Emde, Anna, Daniela A. Ferraro, Nir Ben‐Chetrit, et al.. (2010). Combining epitope-distinct antibodies to HER2: cooperative inhibitory effects on invasive growth. Oncogene. 30(14). 1631–1642. 14 indexed citations

13.

Liu, Hongyu, Chuanbing Zang, Anna Emde, et al.. (2008). Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer. European Journal of Pharmacology. 591(1-3). 43–51. 107 indexed citations

14.

Emde, Anna, et al.. (2007). Combination of fulvestrant and lapatinib in non-HER2-overexpressing and adriamycin-resistant breast cancer cell lines. Journal of Clinical Oncology. 25(18_suppl). 14050–14050. 5 indexed citations

15.

Knösel, Thomas, Anna Emde, Karsten Schlüns, et al.. (2005). Immunoprofiles of 11 Biomarkers Using Tissue Microarrays Identify Prognostic Subgroups in Colorectal Cancer. Neoplasia. 7(8). 741–747. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact